BlueRock Therapeutics

Seth Ettenberg, Ph.D., Chief Scientific Officer
Cambridge, MA
BlueRock Therapeutics is using its unique cell and gene platform to direct cellular differentiation and genetically engineer cells to create an entirely new generation of cellular medicines in the areas of neurology, cardiology, and immunology.

By using this website you agree to accept our Privacy Policy and Terms & Conditions